基于MIMIC-III数据库的ARDS患者的葡萄糖皮质类药物和结果之间的关联
Zhonghua Lu1, Yan Tang2, Mei Liu1
1The First Department of Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province, China.
Medicine
|August 9, 2024
概括
在患有急性呼吸窘迫综合征 (ARDS) 的重症患者中使用葡萄糖皮质激素与更糟糕的结果有关. 这包括更高的死亡率和更长的重症监护室 (ICU) 停留时间,这表明在ARDS患者中谨慎使用这些类固醇.
科学领域:
- 关键护理医学 关键护理医学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性呼吸困扰综合征 (ARDS) 是一种严重的肺部疾病,需要密集护理.
- 糖皮质类药物有时用于ARDS管理,但它们对结果的影响仍在争论中.
- 了解葡萄糖皮质类药物和患者的治疗结果之间的关联对于临床决策至关重要.
研究的目的:
- 为了研究葡萄糖皮质类药物给药与ARDS重症患者的结局之间的关联.
- 分析葡萄糖皮质类药物对ARDS患者死亡率,停留时间和无呼吸器日的影响.
- 为ARDS中葡萄糖皮质类药物的临床使用提供基于证据的见解.
主要方法:
- 从重症监护医疗信息中心 (MIMIC) -III数据库 (2001-2012) 的数据进行了回顾性分析.
- 包括1831名被诊断患有ARDS的成年危急病患者.
- 倾向性得分 (PS) 匹配,以比较葡萄糖皮质醇治疗和对照组之间的结果.
主要成果:
- 葡萄糖皮质激素的使用与增加住院死亡率 (HR 1.32) 和更长的ICU停留 (HR 2.25) 相关.
- 接受葡萄糖皮质类药物治疗的患者的28天无呼吸器日 (HR -2.70) 显著缩短.
- 在15-60天之间的死亡率在葡萄糖皮质醇组 (HR 1.75) 与非葡萄糖皮质醇组相比显著更高.
结论:
- 在ARDS患者中使用葡萄糖皮质类药物与60天和住院生存率的恶化有关.
- 这些发现表明,在使用葡萄糖皮质体剂时,ICU停留时间更长,无呼吸器日减少.
- 在给ARDS患者服用葡萄糖皮质类药物之前,建议进行临床考虑和仔细评估.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
109
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
109
COPD: Management Using Bronchodilators and Corticosteroids
192
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
192
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
232
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
232
Acute Respiratory Failure-V
126
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
126


